2021 Virtual AAN Annual Meeting
posted in Events by dharmendra.asimi@trndigital.com
![](https://impelpharma.com/wp-content/uploads/2022/04/7a5561ec59b4419cbe11263160435a05-1024x538.png)
Impel presented five scientific abstracts as part of the 2021 Virtual American Academy of Neurology Annual Meeting, including data from our pivotal Phase 3 STOP-301 trial of Trudhesa® for the acute treatment of migraine.